A randomized controlled trial of cognitive remediation in schizophrenia.

Schizophrenia Bulletin
Marie Antoinette Redoblado HodgeAnthony Harris

Abstract

Individuals with schizophrenia have consistently been found to exhibit cognitive deficits, which have been identified as critical mediators of psychosocial functional outcomes. Recent reviews of cognitive remediation (CRT) have concluded that these deficits respond to training. This multi-site community study examined 40 individuals with schizophrenia who underwent cognitive remediation using the Neuropsychological Educational Approach to Remediation(1) (NEAR). Assessments using the same neuropsychological tests and measures of psychosocial outcome were made at four time points: baseline, before start of active intervention, end of active intervention and 4 months after end of active intervention. Dose of antipsychotic medication remained constant throughout the study period. After participating in NEAR, individuals showed significant improvements in verbal and visual memory, sustained attention and executive functioning. This effect persisted 4 months after the treatment ceased. The average effect size was mild to moderate. Social and occupational outcomes also improved from baseline to post-treatment, which persisted 4 months later. Our findings replicate those of previous studies that suggest that NEAR is effective in improv...Continue Reading

Associated Clinical Trials

References

Feb 1, 1991·Journal of Consulting and Clinical Psychology·N S Jacobson, P Truax
Jul 1, 1991·Archives of General Psychiatry·A J SaykinP Stafiniak
Jul 1, 1990·Schizophrenia Research·D AddingtonB Schissel
Mar 1, 1996·The American Journal of Psychiatry·M F Green
May 3, 1997·Schizophrenia Research·D I VelliganA L Miller
Mar 21, 1998·Schizophrenia Bulletin·A MedaliaA E Merriam
Mar 31, 1999·Schizophrenia Bulletin·J Addington, D Addington
Nov 30, 2000·Psychological Medicine·A MedaliaM Casey
Dec 6, 2000·Psychiatry Research·A MedaliaS Watras-Gans
May 17, 2001·Schizophrenia Bulletin·A MedaliaM Casey
Sep 12, 2002·Schizophrenia Research·Alice MedaliaMatthew Casey
Jul 17, 2004·The Australian and New Zealand Journal of Psychiatry·Dianne FitzgeraldAnthony Harris
Nov 9, 2004·Schizophrenia Research·Michael F GreenRobert K Heaton
Feb 11, 2005·Acta Psychiatrica Scandinavica·T Ueland, B R Rund
Aug 5, 2005·Schizophrenia Bulletin·Bruce E Wexler, Morris D Bell
May 2, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Til WykesRenee Romeo
Dec 7, 2007·The American Journal of Psychiatry·Susan R McGurkKim T Mueser

❮ Previous
Next ❯

Citations

May 16, 2009·Neuropsychology Review·Alice Medalia, Jimmy Choi
Jan 7, 2011·Journal of the International Neuropsychological Society : JINS·Daniel F HermensIan B Hickie
Oct 25, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak C D'SouzaChittaranjan Andrade
Jun 5, 2012·Acta Neuropsychiatrica·Triptish BhatiaSmita N Deshpande
Jun 6, 2012·Rehabilitation Research and Practice·Sean A KiddBahar Haji Khamneh
Nov 6, 2012·Journal of Psychiatric Research·B Kluwe-SchiavonR Grassi-Oliveira
Nov 26, 2010·Schizophrenia Research·Thierry d'AmatoJérôme Brunelin
Sep 3, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Sharon L NaismithIan B Hickie
Jul 31, 2012·Journal of Affective Disorders·Celia AnayaJan Scott
Apr 26, 2016·Annals of the New York Academy of Sciences·Melissa FisherSophia Vinogradov
Aug 11, 2016·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Posen LeeChing-Lin Hsieh
Jun 21, 2013·The Australian and New Zealand Journal of Psychiatry·Bhing-Leet Tan, Robert King
Apr 10, 2013·The Australian and New Zealand Journal of Psychiatry·Frances DarkAnthony Harris
May 18, 2017·Expert Review of Neurotherapeutics·Michael W Best, Christopher R Bowie
Mar 29, 2011·The Australian and New Zealand Journal of Psychiatry·Cali F BartholomeuszStephen J Wood
Feb 2, 2018·Frontiers in Psychiatry·Tamiko Mogami
Dec 8, 2017·Neuropsychological Rehabilitation·Akihiko KatsumiShin-Ichi Niwa
May 3, 2018·CNS Spectrums·Alice MedaliaLloyd I Sederer
Jun 11, 2019·The Australian and New Zealand Journal of Psychiatry·Maree P ReserSusan L Rossell
Aug 30, 2018·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Susan NoyesMarian Arbesman
Sep 19, 2015·Current Opinion in Psychiatry·Unna N DannerJoanna Steinglass
Jul 16, 2019·Psychiatry Research·Monika MakJerzy Samochowiec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here